Quipt Home Medical Corp.

NASDAQ•QIPT

CEO: Mr. Gregory J. Crawford

セクター: Healthcare

業種: Medical - Devices

上場日: 2010-08-10

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

連絡先情報

1019 Town Drive, Wilder, KY, 41076, United States

859-878-2220

quipthomemedical.com

時価総額

$162.30M

PER (TTM)

-14.8

23.8

配当利回り

52週高値

$3.65

52週安値

$1.35

52週レンジ

100%

順位50Top 68.9%

3.1

F-Score

改良版 Piotroski 分析

10年ファンダメンタル

弱い • 3.1 / 9 ポイント

スコアレンジ (0-9)

8-9: 価値が優れている

6-7: 基礎体質が強い

4-5: 全体的に堅調

0-3: パフォーマンスが弱い

データ期間: 2016-2025

財務ダッシュボード

Q1 2026 データ

売上高

$81.00M+0.00%

直近4四半期の推移

EPS

-$0.02+0.00%

直近4四半期の推移

フリーCF

$6.97M+0.00%

直近4四半期の推移

2026 Q1 決算ハイライト

主なハイライト

Revenue Growth Strong Total revenue reached $81.0M USD for the quarter, marking a 32% increase from $61.4M USD last year, driven by recent acquisitions.

Operating Income Improvement Operating income rose substantially to $1.02M USD compared to $448K USD in the prior year period, showing improved core profitability.

Net Loss Slightly Reduced Quarterly net loss decreased marginally to $1.05M USD versus $1.08M USD reported previously, resulting in better basic loss per share.

Stable Operating Cash Flow Net cash flow provided by operating activities was $8.94M USD, remaining relatively flat compared to $9.30M USD last year.

リスク要因

Arrangement Closing Uncertainty Consummation of the acquisition agreement is subject to shareholder vote and regulatory approvals; failure could negatively impact share price.

DOJ Investigation Ongoing Company faces a civil investigative demand from the DOJ regarding CPAP equipment claims, posing an uncertain material adverse risk.

Increased Stock Compensation Stock-based compensation expense increased sharply to $982K USD from $207K USD, reflecting new long-term incentive grants.

Operating Restrictions Pending The Arrangement Agreement imposes covenants restricting strategic initiatives until closing, potentially delaying response to market changes.

見通し

Future Growth Priorities Set Priorities focus on driving organic revenue growth, achieving operational net profit, and expanding Adjusted EBITDA beyond current fiscal year.

Post-Acquisition Integration Focus Management is optimizing organizational structure and centralizing back-office processes to support scalable long-term growth following recent deals.

Sufficient Liquidity Expected Current cash on hand of $10.54M USD and credit availability are expected to fund operations for the next twelve months.

Debt Repayment Schedule The $110.0M USD senior credit facility has $84.0M USD outstanding, with scheduled principal repayments commencing in 2026.

同業比較

売上高 (TTM)

DCGO

$322.20M

-47.7%

QIPT

$285.31M

+19.3%

MGNX

$149.50M

+0.8%

粗利益率 (最新四半期)

RCEL

81.2%

-2.4pp

QIPT

71.9%

+104.6pp

ANIK

62.6%

+52.3pp

主要指標

銘柄コード	時価総額	PER (TTM)	ROE (TTM)	負債比率
PRE	$249.46M	-4.9	-36.0%	1.1%
MGNX	$223.72M	-3.0	-120.2%	41.6%
ANIK	$220.36M	-20.0	-7.4%	12.7%

長期トレンド

直近4四半期

売上高

純利益

営業キャッシュフロー

4四半期売上高CAGR

12.2%

安定成長

4四半期純利益CAGR

N/M

収益構造の変化

キャッシュフロー安定性

100%

優れたキャッシュフローの実績

深度リサーチ

次回決算:2026年5月11日

EPS:-

売上高:-

財務データ

決算説明会

財務レポート

ニュース

損益計算書

バランスシート

キャッシュフロー計算書

財務比率

変化率

損益計算書	直近12ヶ月

データなし